X
Xiaoying Li
Researcher at Fudan University
Publications - 232
Citations - 12574
Xiaoying Li is an academic researcher from Fudan University. The author has contributed to research in topics: Diabetes mellitus & Insulin resistance. The author has an hindex of 42, co-authored 192 publications receiving 10218 citations. Previous affiliations of Xiaoying Li include Chinese Academy of Sciences & Xiamen University.
Papers
More filters
Journal ArticleDOI
Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases
Xi Chen,Yi Ba,Lijia Ma,Lijia Ma,Xing Cai,Yuan Yin,Kehui Wang,Jigang Guo,Yujing Zhang,Jiangning Chen,Xing Guo,Qibin Li,Qibin Li,Xiaoying Li,Wenjing Wang,Yan Zhang,Jin Wang,Xueyuan Jiang,Yang Xiang,Chen Xu,Pingping Zheng,Juanbin Zhang,Ruiqiang Li,Hongjie Zhang,Xiaobin Shang,Ting Gong,Guang Ning,Jun Wang,Jun Wang,Ke Zen,Junfeng Zhang,Chen-Yu Zhang +31 more
TL;DR: It is demonstrated that miRNAs are present in the serum and plasma of humans and other animals such as mice, rats, bovine fetuses, calves, and horses, and can serve as potential biomarkers for the detection of various cancers and other diseases.
Journal ArticleDOI
Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats.
Xu Zhang,Yufeng Zhao,Menghui Zhang,Xiaoyan Pang,Jia Xu,Chaoying Kang,Meng Li,Chenhong Zhang,Zhiguo Zhang,Yifei Zhang,Xiaoying Li,Guang Ning,Liping Zhao +12 more
TL;DR: The findings suggest that the prevention of obesity and insulin resistance by berberine in HFD-fed rats is at least partially mediated by structural modulation of the gut microbiota, which may help to alleviate inflammation by reducing the exogenous antigen load in the host and elevating SCFA levels in the intestine.
Journal ArticleDOI
Treatment of Type 2 Diabetes and Dyslipidemia with the Natural Plant Alkaloid Berberine
Yifei Zhang,Xiaoying Li,Dajin Zou,Wei Liu,Jialin Yang,Na Zhu,Li Huo,Miao Wang,Jie Hong,Peihong Wu,Guoguang Ren,Guang Ning +11 more
TL;DR: Berberine is effective and safe in the treatment of type 2 diabetes and dyslipidemia and the glucose disposal rate was increased after berberine treatment, although no significant change was found between berberines and placebo groups.
Journal ArticleDOI
Standards of medical care for type 2 diabetes in China 2019.
Weiping Jia,Jianping Weng,Dalong Zhu,Linong Ji,Juming Lu,Zhiguang Zhou,Dajin Zou,Lixin Guo,Qiuhe Ji,Li Chen,Liming Chen,Jingtao Dou,Xiaohui Guo,Hongyu Kuang,Ling Li,Qifu Li,Xiaoying Li,Jing Liu,Xingwu Ran,Lixin Shi,Guangyao Song,Xinhua Xiao,Liyong Yang,Zhigang Zhao +23 more
TL;DR: The main contents include epidemiology of type 2 diabetes in China; diagnosis and classification of diabetes; primary, secondary, and tertiary diabetes prevention; diabetes education and management support; blood glucose monitoring; integrated control targets for type 1 diabetes and treatments for hyperglycaemia.
Journal ArticleDOI
Urinary bisphenol A (BPA) concentration associates with obesity and insulin resistance.
Tiange Wang,Mian Li,Bing Chen,Min Xu,Yu Xu,Yun Huang,Jieli Lu,Yuhong Chen,Weiqing Wang,Xiaoying Li,Yu Liu,Yufang Bi,Shenghan Lai,Guang Ning +13 more
TL;DR: BPA was positively associated with generalized obesity, abdominal obesity, and insulin resistance in middle-aged and elderly Chinese adults.